Trial Profile
Standard versus intensive therApy by Rosuvastatin for lipiD lowering
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms SARD
- 30 Nov 2012 Planned End Date changed from 1 Mar 2013 to 30 Dec 2012 as reported by University Hospital Medical Information Network - Japan record..
- 03 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 02 Dec 2011 New trial record